Ethical challenges of travel for experimental therapy in malignant brain tumor patients
J Neurosurg
.
2023 Jun 2;139(6):1802-1806.
doi: 10.3171/2023.4.JNS2369.
Authors
Manuela Vooijs
1
2
,
Faith C Robertson
2
,
Gail Rosseau
3
,
Anastasia Tasiou
4
,
Ana Rodríguez-Hernández
5
,
Stiliana I Mihaylova
6
,
Mary Murphy
7
,
Marike L D Broekman
8
9
Affiliations
1
1VU University Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, The Netherlands.
2
2Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
3
3Department of Neurosurgery, George Washington University School of Medicine and Health Sciences, Washington, DC.
4
4Department of Neurosurgery, University Hospital of Larissa, Greece.
5
5Department of Neurological Surgery, Germans Triasi Pujol University Hospital, Barcelona, Spain.
6
6Department of Neurosurgery, University Hospital St. Ivan Rilski, Sofia, Bulgaria.
7
7Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
8
8Department of Neurosurgery, Haaglanden Medical Center, Den Haag, The Netherlands; and.
9
9Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands.
PMID:
37310061
DOI:
10.3171/2023.4.JNS2369
No abstract available
MeSH terms
Brain Neoplasms* / therapy
Humans
Therapies, Investigational
Travel*